Journal of Cardiology and Heart Failure

Dr. Yongting Luo graduated with a Ph.D. degree in Cell Biology from the Institute of Biophysics, Chinese Academy of Sciences in 2012. He is a professor at the Department of Nutrition and Health of China Agricultural University. He has received 10 scientific awards and participated in 21 scientific projects, being the coordinator in 9 projects. His current research interests focus on Cell metabolism, vascular biology, and nutritional intervention for cardiovascular diseases. To date, he has published 68 academic papers in internationally renowned journals, including European Heart Journal, Blood, Science Bulletin, Cell Research, Nature Communications, PNAS, Cell Reports, Protein Cell, International Journal of Surgery, Cell Death & Disease, and the American Journal of Clinical Nutrition.

• Nutritional intervention for cardiovascular diseases
• Pharmaceutical Innovation
• vascular biology
• cardiovascular diseases
• Cell metabolism

Academic Positions – Associate Professor & Doctoral Supervisor, Department of Nutrition and Health, China Agricultural University (since 2016).

1. Peer Review Expert of National Natural Science Foundation of China
2. Peer Review Expert of Beijing Natural Science Foundation
3. Thesis Review Expert, Ministry of Education
4. National Graduate Education Evaluation Expert
5. Beijing Agricultural Science & Technology Expert

Memberships

1. Member, American Society for Nutrition (ASN)
2. Member, European Society of Cardiology (ESC)
3. Reviewer Service – Reviewer for top journals including Nature Communications, PNAS, Signal Transduction and Targeted Therapy, Clinical and Translational Medicine, American Journal of Clinical Nutrition, Biomedicines, Biomolecules, Cells, European Journal of Pharmacology, Pharmaceuticals, Life Sciences, Nutrients, FASEB Journal.

Editorial Roles

1. Guest Editor: Antioxidants, Frontiers in Nutrition, Nutrients
2. Editorial Board Member: Cardiology and Cardiovascular Research, Nutrients
3. Research Funding – Principal Investigator on multiple National Key R&D Programs of China (2022–2027), National Natural Science Foundation of China (2014–2025), and Beijing Municipal Natural Science Foundation (2022–2024).

Awards

1. Xingnong Cup Innovation & Entrepreneurship Competition – Third Prize (2022)
2. Beijing Science & Technology Award – First Prize (2014)
3. IUPAB Young Scientist Travel Award (2011)
4. Scholarship, Institute of Biophysics, CAS (2012)

Invited Speaker – At major international conferences, including AACR (Boston, 2019), AACR New Horizons in Cancer Research (Shanghai, 2014), and ABA Symposium (China, 2014).

1. Luo Y* et al. The AP-1 complex governs a vascular degenerative transcriptional program in smooth muscle cells to trigger aortic dissection and rupture. Eur Heart J. 2024;45(4):287-305.

2. Zhu L, Li D, Zhang X, Wan S, et al. Comparative efficacy of C-CABG, OPCAB and ONBEAT in coronary heart disease: a systematic review and network meta-analysis. Int J Surg. 2023.

3. Xu T, Zhang X, Zhao W, Wan S, et al. Foxo1 is an iron-responsive transcription factor regulating systemic iron homeostasis. Blood. 2024.

4. Zhao W, Chen J, Xia Y, Wan S, et al. Single cell atlas of type A aortic dissection reveals immune cell dynamics and therapeutic targets. Science Bulletin. 2024.

5. Luo Y, Duan H, Qian Y, et al. Macrophagic CD146 promotes foam cell formation and retention in atherosclerosis. Cell Research. 2017. (Cover Story)

6. Chen J, Luo Y, Hui H, et al. CD146 coordinates endothelial cell–pericyte communication for blood–brain barrier development. PNAS. 2017. (Faculty 1000 Recommended)

7. Luo Y, Teng X, Zhang L, et al. CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension. Nat Commun. 2019;10:3551.

8. Xu W, Hua H, Chiu YH, et al. CD146 regulates mTORC2 activity independent of PI3K/mTORC1 pathways. Cell Reports. 2019.

9. Zhang L, Luo Y, Teng X, et al. CD146 as a therapeutic target for systemic sclerosis. Protein & Cell. 2018.

10. Chen J, Luo Y, Huang H, et al. CD146 is essential for PDGFRβ-induced pericyte recruitment. Protein & Cell. 2018.

11. Wang X, Ji Y, Qi J, Zhou S, Wan S, et al. Mitochondrial carrier 1 governs ferroptosis via FoxO1-GPX4 axis in cervical cancer cells. Cell Death & Disease. 2023.

12. Xu T, Zhang X, Liu Y, Wang H, et al. Dietary polyphenol supplementation on iron status: a systematic review and meta-analysis. Am J Clin Nutr. 2021.

13. Qi J, Zhou S, Wang Z, Xia Y, Xu T, et al. Dendrobium officinale polysaccharide alleviates atherosclerosis by modulating metabolism and gut microbiota. Antioxidants. 2024.

14. Zhou S, Wang Z, Hao Y, An P, Luo J, Luo Y#. Dandelion polysaccharides ameliorated high-fat-diet-induced atherosclerosis. Nutrients. 2023.

15. Luo J, Luo Y#. Effects of dietary protein and polysaccharide fortification on disease. Nutrients. 2023.

16. Qi J, An P, Luo Y#, Luo J#. Food groups and urologic cancer risk: systematic review and meta-analysis. Front Nutr. 2023.

17. Zhu L, An P, Zhao W, Xia Y, Qi J, Luo J#, Luo Y#. Low zinc alleviates thoracic aortic dissection progression by inhibiting inflammation. Nutrients. 2023.

18. Wang Z, Jin D, Zhou S, Dong N, Ji Y, An P, Wang J#, Luo Y#, Luo J#. Regulatory role of copper metabolism and cuproptosis in cancer. Front Oncol. 2023.

19. Sun Y, Ren F, Luo Y#, Li Y#. mTORC2: multifaceted regulator of autophagy. Cell Communication and Signaling. 2023.

20. Guo X, Luo J, Qi J, Zhao X, An P, Luo Y#, Wang G#. The role and mechanism of polysaccharides in anti-aging. Nutrients. 2022.